KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Other financing activities (2016 - 2025)

Historic Other financing activities for Biolife Solutions (BLFS) over the last 9 years, with Q3 2025 value amounting to $9000.0.

  • Biolife Solutions' Other financing activities fell 4375.0% to $9000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of -$74000.0 for FY2024, which is 21562.5% down from last year.
  • Biolife Solutions' Other financing activities amounted to $9000.0 in Q3 2025, which was down 4375.0% from $10000.0 recorded in Q2 2025.
  • Biolife Solutions' 5-year Other financing activities high stood at $145000.0 for Q3 2021, and its period low was -$312000.0 during Q3 2022.
  • Over the past 5 years, Biolife Solutions' median Other financing activities value was $9000.0 (recorded in 2023), while the average stood at -$9611.1.
  • Within the past 5 years, the most significant YoY rise in Biolife Solutions' Other financing activities was 122857.14% (2021), while the steepest drop was 102857.14% (2021).
  • Over the past 5 years, Biolife Solutions' Other financing activities (Quarter) stood at $145000.0 in 2021, then tumbled by 124.14% to -$35000.0 in 2022, then skyrocketed by 62.86% to -$13000.0 in 2023, then plummeted by 346.15% to -$58000.0 in 2024, then soared by 115.52% to $9000.0 in 2025.
  • Its Other financing activities was $9000.0 in Q3 2025, compared to $10000.0 in Q2 2025 and $10000.0 in Q1 2025.